Sun Pharmaceutical Industries Overview
- Year Founded
-
1983
- Status
-
Public
- Employees
-
28,925
- Stock Symbol
-
SUNPHARMA
- Investments
-
46
- Share Price
-
$19.99
- (As of Friday Closing)
Sun Pharmaceutical Industries General Information
Description
Sun Pharmaceuticals Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and Active Pharmaceutical ingredients(APIs). The Company has various manufacturing locations spread across the country with trading and other incidental and related activities extending to the world-wide market. The company's reportable segments are India, United States of America, Emerging markets, and Rest of the world. The company generates majority of revenue from India. Its products are Speciality Medications, Generic Medications, Over-the-Counter Medications, Active Pharmaceutical Ingredients, and Anti Retro Viral Medications.
Contact Information
Website
www.sunpharma.comCorporate Office
- Sun House CTS Number 201 B/1
- Western Express Highway, Goregaon East
- Mumbai, Maharashtra 400063
- India
Corporate Office
- Sun House CTS Number 201 B/1
- Western Express Highway, Goregaon East
- Mumbai, Maharashtra 400063
- India
Sun Pharmaceutical Industries Stock Performance
As of 13-Nov-2026, Sun Pharmaceutical Industries’s stock price is $19.99. Its current market cap is $48B with 2.4B shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.99 | $20.12 | $17.15 - $21.39 | $48B | 2.4B | 1.79M | $0.49 |
Sun Pharmaceutical Industries Financials Summary
As of 30-Sep-2026, Sun Pharmaceutical Industries has a trailing 12-month revenue of $6.61B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 42,375,181 | 41,962,711 | 46,477,871 | 45,385,245 |
| Revenue | 6,612,708 | 6,588,688 | 6,154,560 | 5,768,915 |
| EBITDA | 1,982,347 | 1,978,259 | 1,812,826 | 1,553,435 |
| Net Income | 1,182,730 | 1,299,110 | 1,292,502 | 1,156,765 |
| Total Assets | 11,955,960 | 11,529,647 | 10,767,049 | 10,252,555 |
| Total Debt | 337,454 | 490,428 | 276,153 | 392,557 |
Sun Pharmaceutical Industries Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sun Pharmaceutical Industries Comparisons
Industry
Financing
Details
Sun Pharmaceutical Industries Competitors (39)
One of Sun Pharmaceutical Industries’s 39 competitors is Glenmark Pharmaceuticals, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals | Corporation | Mumbai, India | ||||
| Mankind Pharma | Formerly PE-Backed | New Delhi, India | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Jubilant Pharmova | Corporation | Noida, India | ||||
| Panacea Biotec | Corporation | New Delhi, India |
Sun Pharmaceutical Industries Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sun Pharmaceutical Industries Patents
Sun Pharmaceutical Industries Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026188143-A1 | Methods and compositions for treating plaque and scalp psoriasis in obese patients | Pending | 07-Mar-2025 | ||
| WO-2025079063-A2 | An aqueous solution of cholecalciferol | Pending | 11-Feb-2025 | ||
| WO-2025079063-A3 | An aqueous solution of cholecalciferol | Pending | 11-Feb-2025 | ||
| WO-2026110108-A1 | Methods of detecting host cell proteins | Pending | 22-Nov-2024 | ||
| WO-2026069253-A1 | Long term safety of tildrakizumab in psoriatic arthritis | Pending | 30-Sep-2024 | C07K16/244 |
Sun Pharmaceutical Industries Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sun Pharmaceutical Industries Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sun Pharmaceutical Industries Investments & Acquisitions (46)
Sun Pharmaceutical Industries’s most recent deal was a Merger/Acquisition with Innovcare Lifesciences for . The deal was made on 20-Jun-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Innovcare Lifesciences | 20-Jun-2026 | Merger/Acquisition | Distributors (Healthcare) | ||
| Organon | 26-Apr-2026 | Merger/Acquisition | Pharmaceuticals | ||
| HaystackAnalytics | 13-Mar-2026 | Later Stage VC | Decision/Risk Analysis | ||
| Pharmazz | 11-Jun-2025 | Later Stage VC | Pharmaceuticals | ||
| Checkpoint Therapeutics | 30-May-2025 | Merger/Acquisition | Biotechnology |
Sun Pharmaceutical Industries ESG
Risk Overview
Risk Rating
Updated November, 06, 2026
24.28 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Sun Pharmaceutical Industries Exits (3)
Sun Pharmaceutical Industries’s most recent exit was on 21-Dec-2023 from Lyndra Therapeutics. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Lyndra Therapeutics | 21-Dec-2023 | Completed |
|
||
| Krystal Biotech | 09-Aug-2017 | Completed |
|
||
| ScPharmaceuticals | 23-Dec-2016 | Early Stage VC | Completed |
|
Sun Pharmaceutical Industries Affiliates
Subsidiaries (12)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Sun Pharma Canada | Brampton, Canada | 2025 | |
| Ranbaxy Signature | Princeton, NJ | 2020 | |
| Checkpoint Therapeutics | Waltham, MA | 2014 | |
| Vivaldis Health and Foods | Pune, India | 2014 | |
| Url Pharmpro | Aurora, IL | 2009 |
Sun Pharmaceutical Industries FAQs
-
When was Sun Pharmaceutical Industries founded?
Sun Pharmaceutical Industries was founded in 1983.
-
Where is Sun Pharmaceutical Industries headquartered?
Sun Pharmaceutical Industries is headquartered in Mumbai, India.
-
What is the size of Sun Pharmaceutical Industries?
Sun Pharmaceutical Industries has 28,925 total employees.
-
What industry is Sun Pharmaceutical Industries in?
Sun Pharmaceutical Industries’s primary industry is Pharmaceuticals.
-
Is Sun Pharmaceutical Industries a private or public company?
Sun Pharmaceutical Industries is a Public company.
-
What is Sun Pharmaceutical Industries’s stock symbol?
The ticker symbol for Sun Pharmaceutical Industries is SUNPHARMA.
-
What is the current stock price of Sun Pharmaceutical Industries?
As of 13-Nov-2026 the stock price of Sun Pharmaceutical Industries is $19.99.
-
What is the current market cap of Sun Pharmaceutical Industries?
The current market capitalization of Sun Pharmaceutical Industries is $48B.
-
What is Sun Pharmaceutical Industries’s current revenue?
The trailing twelve month revenue for Sun Pharmaceutical Industries is $6.61B.
-
Who are Sun Pharmaceutical Industries’s competitors?
Glenmark Pharmaceuticals, Mankind Pharma, Evonile Pharma, Jubilant Pharmova, and Panacea Biotec are some of the 39 competitors of Sun Pharmaceutical Industries.
-
What is Sun Pharmaceutical Industries’s annual earnings per share (EPS)?
Sun Pharmaceutical Industries’s EPS for 12 months was $0.49.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
